(S (PP (IN For) (NP (NN prostate) (NN cancer) (NNS patients))) (, ,) (NP (DT the) (NN Gleason) (NN score)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (JJ important)) (JJ prognostic) (NNS factors)))) (, ,) (S (ADVP (RB potentially)) (VP (VBG determining) (NP (NP (NN treatment) (JJ independent)) (PP (IN of) (NP (DT the) (NN stage))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NN Gleason) (NN scoring)) (VP (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (JJ subjective) (JJ microscopic) (NN examination)) (PP (IN of) (NP (NN tumor) (NN morphology))))))) (CC and) (VP (VBZ suffers) (PP (IN from) (NP (JJ poor) (NN reproducibility))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (DT a) (NML (JJ deep) (NN learning)) (NN system) (PRN (-LRB- -LRB-) (NP (NN DLS)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NN Gleason)) (VP (VBG scoring) (NP (NP (NML (JJ whole) (HYPH -) (NN slide)) (NNS images)) (PP (IN of) (NP (NNS prostatectomies)))))))) (. .))
(S (NP (PRP$ Our) (NN system)) (VP (VBD was) (VP (VP (VBN developed) (S (VP (VBG using) (NP (ADJP (NP (QP (CD 112) (CD million)) (NN pathologist)) (HYPH -) (VBN annotated)) (NN image) (NNS patches)) (PP (IN from) (NP (CD 1,226) (NNS slides)))))) (, ,) (CC and) (VP (VBN evaluated) (PP (IN on) (NP (NP (DT an) (JJ independent) (NN validation) (NN dataset)) (PP (IN of) (NP (CD 331) (NNS slides))))) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN reference) (NN standard)) (VP (VBD was) (VP (VBN established) (PP (IN by) (NP (JJ genitourinary) (NN specialist) (NNS pathologists)))))))))) (. .))
(S (PP (IN On) (NP (DT the) (NN validation) (NN dataset))) (, ,) (NP (NP (DT the) (JJ mean) (NN accuracy)) (PP (IN among) (NP (CD 29) (JJ general) (NNS pathologists)))) (VP (VBD was) (NP (CD 0.61))) (. .))
(S (NP (DT The) (NNP DLS)) (VP (VP (VBD achieved) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (JJ diagnostic) (NN accuracy)) (PP (IN of) (NP (CD 0.70)))) (PRN (-LRB- -LRB-) (S (NP (NN p)) (VP (SYM =) (NP (CD 0.002)))) (-RRB- -RRB-))) (CC and) (VP (VBN trended) (PP (IN towards) (NP (NP (ADJP (JJR better) (JJ patient)) (NN risk) (NN stratification)) (PP (IN in) (NP (NNS correlations))))) (PP (IN to) (NP (JJ clinical) (NML (NN follow) (HYPH -) (NN up)) (NNS data))))) (. .))
(S (NP (PRP$ Our) (NN approach)) (VP (MD could) (VP (VB improve) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (NP (NN Gleason) (NN scoring)) (CC and) (NP (JJ subsequent) (NN therapy) (NNS decisions))))) (, ,) (SBAR (ADVP (RB particularly)) (WHADVP (WRB where)) (S (NP (JJ specialist) (NN expertise)) (VP (VBZ is) (ADJP (JJ unavailable))))))) (. .))
(S (NP (DT The) (NNP DLS)) (ADVP (RB also)) (VP (VBZ goes) (PP (IN beyond) (NP (DT the) (JJ current) (NN Gleason) (NN system))) (S (VP (TO to) (ADVP (RBR more)) (ADVP (RB finely)) (VP (VB characterize) (CC and) (VB quantitate) (NP (NP (NN tumor) (NN morphology)) (, ,) (VP (VBG providing) (NP (NNS opportunities)) (PP (IN for) (NP (NP (NN refinement)) (PP (IN of) (NP (DT the) (NN Gleason) (NN system))))) (NP (PRP itself)))))))) (. .))
